India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 24.08 42.49
Tata Stl 136.20 30.33
Ong Corp 256.00 95.64
I T C Lt 438.65 28.62
Ntpc Ltd 319.00 89.15
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Glenmark Pharmaceutical Limited
Glenmark Pharmaceutical Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:532296NSE:GLENMARKBloomberg:GNP@INReuters:GLEN.BO
Market Lot: 1Face Value: 1ISIN Demat: INE935A01035
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
09-Feb-2022       Glenmark launches Nitric Oxide Nasal Spray in India IRIS
17-Jan-2022       Glenmark Pharmaceuticals arm gets tentative approval for Regadenoson Injection  IRIS
11-Oct-2021       Glenmark launches Tavulus for COPD treatment in Spain IRIS
30-Sep-2021       Glenmark receives marketing approval for Ryaltris in 13 countries across EU and UK  IRIS
21-Sep-2021       Glenmark Pharmaceuticals receives USFDA approval for Clindamycin Phosphate Foam IRIS
27-Jul-2021       Glenmark Life Sciences IPO opens today IRIS
25-Jun-2021       Glenmark Pharmaceutical receives ANDA approval for Nintedanib Capsules IRIS
23-Jun-2021       Glenmark gets ANDA approval for inhalation product IRIS
18-Jun-2021       Glenmark launches Tiogiva in UK for treatment of COPD IRIS
04-Jun-2021       Glenmark Pharma receives ANDA approval for Theophylline ExtendedRelease Tablets IRIS
01-Jun-2021       Glenmark Pharmaceuticals launches Rufinamide Tablets USP IRIS
24-May-2021       Glenmark Pharmaceuticals receives ANDA approval for Icatibant Injection  IRIS
24-Mar-2021       Glenmark gets ANDA approval for Chlorpromazine Hydrochloride Tablets IRIS
23-Mar-2021       Glenmark gets ANDA approval for Diltiazem Hydrochloride Extended-Release Capsules  IRIS
22-Mar-2021       Glenmark, Bausch Health join hands to commercialize RYALTRIS nasal spray in Canada  IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
� All rights reserved. IRIS Business Services Limited
Disclaimer